Bayer AG: Putting Down Bucks
This article was originally published in Start Up
Executive Summary
Bayer AG is expanding its investment in the US, focusing particularly on its health care businesses. It plans to spend $5.1 billion on pharmaceutical research in the next 4-5 years in the US, adding 200 scientists and building a huge new facility near its existing labs in Connecticut. Some of the money will go to outside companies, as well.